Stockreport

Palvella Therapeutics Announces Pricing of Upsized Public Offering

Palvella Therapeutics, Inc.  (PVLA) 
PDF WAYNE, Pa., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (“Palvella”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing [Read more]